Mr. Banko is Director, Health Economics and Outcomes Research at B. Braun Medical Inc. located in Bethlehem, Pennsylvania. He is responsible for identifying strategies to leverage health economics and outcomes studies across the breadth of B. Braun’s portfolio resulting in the differentiation of their products in a highly competitive market. Mr. Banko partners with all levels of the Organization to develop an optimized evidence generation plan ensuring widespread adoption of their innovative products upon commercialization. Mr. Banko is leading B. Braun Medical Inc in preparing for the challenges and opportunities associated with the transition to a value oriented healthcare system in the United States.
Mr. Banko has been with B. Braun Medical for the past eight years and now has over 25-years of combined experience with pharmaceutical, medical device, diagnostics and hospital finance experience. Prior to joining B. Braun, he previously spent 12 years working with two operating companies that were part of the Johnson & Johnson family of companies. During his time with J&J, he successfully leveraged outcomes evidence to shape Medicare’s National medical coverage and reimbursement policies and developed programs to assist hospitals and physicians in securing market access from Medicare and other third-party payors for FDA approved emerging medical device technologies.
He has lead efforts in developing responses to payer’s Health Technology Assessments (HTAs) and in educating internal business partners on the implications of major policy shifts such as Medicare’s bundled payment initiatives, comparative (cost) effectiveness and gainsharing.
Mr. Banko gained extensive experience in health care finance and reimbursement working with healthcare systems in Northeastern Pennsylvania.
He received a B.S. degree in Liberal Studies from the University of Scranton and a M.S. degree in Finance from King’s College. Mr. Banko is a Certified Public Accountant, licensed in the State of Pennsylvania.
Mr. Banko has been with B. Braun Medical for the past eight years and now has over 25-years of combined experience with pharmaceutical, medical device, diagnostics and hospital finance experience. Prior to joining B. Braun, he previously spent 12 years working with two operating companies that were part of the Johnson & Johnson family of companies. During his time with J&J, he successfully leveraged outcomes evidence to shape Medicare’s National medical coverage and reimbursement policies and developed programs to assist hospitals and physicians in securing market access from Medicare and other third-party payors for FDA approved emerging medical device technologies.
He has lead efforts in developing responses to payer’s Health Technology Assessments (HTAs) and in educating internal business partners on the implications of major policy shifts such as Medicare’s bundled payment initiatives, comparative (cost) effectiveness and gainsharing.
Mr. Banko gained extensive experience in health care finance and reimbursement working with healthcare systems in Northeastern Pennsylvania.
He received a B.S. degree in Liberal Studies from the University of Scranton and a M.S. degree in Finance from King’s College. Mr. Banko is a Certified Public Accountant, licensed in the State of Pennsylvania.